Saturday, April 29, 2023 6:40:52 PM
UGA senior, 21, dies six weeks after diagnosed with stage 4 tumor
A University of Georgia senior has died six weeks after she was diagnosed with a stage 4 tumor that caused a horrific brain bleed while in Mexico on Spring Break. Liza Burke (pictured), 21, spent the last few weeks fighting for her life after doctors from the Mayo Clinic diagnosed her with a grade four astrocytoma glioma, a malignant and aggressive tumor located on the brain stem that grows rapidly. Burke was on vacation in Cabo San Lucas, Mexico with her boyfriend and 53 of his fraternity brothers and their friends, when she suffered a brain hemorrhage. Burke was rushed to a hospital in Mexico before she was air lifted to the Mayo Clinic in Jacksonville, Florida on March 10. Read the full story: https://www.dailymail.co.uk/news/article-12026367/UGA-senior-21-dies-six-weeks-afer-diagnosed-stage-4-tumor.html?ito=msngallery
A University of Georgia senior has died six weeks after she was diagnosed with a stage 4 tumor that caused a horrific brain bleed while in Mexico on Spring Break. Liza Burke (pictured), 21, spent the last few weeks fighting for her life after doctors from the Mayo Clinic diagnosed her with a grade four astrocytoma glioma, a malignant and aggressive tumor located on the brain stem that grows rapidly. Burke was on vacation in Cabo San Lucas, Mexico with her boyfriend and 53 of his fraternity brothers and their friends, when she suffered a brain hemorrhage. Burke was rushed to a hospital in Mexico before she was air lifted to the Mayo Clinic in Jacksonville, Florida on March 10. Read the full story: https://www.dailymail.co.uk/news/article-12026367/UGA-senior-21-dies-six-weeks-afer-diagnosed-stage-4-tumor.html?ito=msngallery
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
